The U.S. Department of Defense’s Peer Reviewed Medical Research Program (PRMRP) included peripheral neuropathy as a condition eligible for research funding for the first time ever in 2021. The Foundation for Peripheral Neuropathy (FPN) is proud to have been instrumental in making more funding available for PN research and researchers. For a second consecutive year, …
PRMRP Research Funding FY22: Now Accepting Applications Read More »
The Foundation for Peripheral Neuropathy is pleased to announce that peripheral neuropathy has been renewed as an eligible condition for Department of Defense (DOD) funds for the upcoming year. The Bill recently made it into law and FPN is proud that its lobbying campaign this past year was a success! Peer-Reviewed Medical Research Program The …
The Department of Defense’s (DoD) Peer-Reviewed Medical Research Program (PRMRP) has determined the grant applications that it wishes to award in fiscal year 2021 (FY21). In this first year that applications were accepted for research in peripheral neuropathy, 41 applications out of over 1000 applications received focused on peripheral neuropathy. DoD is recommending awarding a grant …
A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®. The Foundation for Peripheral Neuropathy (FPN) is pleased to announce that Lindsay Colbert, Executive Director, was among the few esteemed authors on the subcommittee for this important review and update. …
AAN’s New Painful Diabetic Polyneuropathy Guidelines Read More »
Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels …
Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to …
The Foundation for Peripheral Neuropathy (FPN) applauds action taken by Congress to designate “peripheral neuropathy” as a condition eligible for research funding from the Department of Defense’s (DoD) Peer Reviewed Medical Research Program (PRMRP). Language designating the condition eligible for funding is included in the fiscal year 2021 Omnibus Appropriations Act cleared yesterday by the …
FPN Applauds Congressional Action to Increase Research for Peripheral Neuropathy Read More »
Exercise to Help Patients with Idiopathic Neuropathy Research has consistently demonstrated that regular exercise reduces polyneuropathy (PN) symptoms in patients with type 2 diabetes. Patients with prediabetes or metabolic syndrome have also shown to benefit from regular exercise. Exercise has also shown to slow progression of peripheral neuropathy in these patient groups. However, little is …
Can Exercise Help Patients with Idiopathic Peripheral Neuropathy? Read More »
Following the Foundation for Peripheral Neuropathy‘s (FPN) recent webinar on current research trends, Lindsay Colbert, FPN’s Executive Director, caught up with the program’s panelists, Dr. Senda Ajroud-Driss, Dr. Ahmet Höke and Dr. Gordon Smith to follow-up on some important questions that the program did not have time to cover. In this “Ask the Expert” series, …
Ask the Expert: Popular Questions from PN Patients Read More »
FPN Advocates for Peripheral Neuropathy Research Funding Ongoing, the Foundation for Peripheral Neuropathy (FPN) has been working with a consultant to advocate for more federal funding for peripheral neuropathy research. With the election almost behind us, we again are looking to ramp up our efforts. Update on the 2021 Appropriations Bill On November 10, 2020, …
